A health worker draws a dose of Pfizer-BioNTech coronavirus disease (COVID-19) vaccine from a vial during a vaccination event hosted by Miami – Dade County and Miami Heat, at FTX Arena in Miami, Florida, U.S., August 5, 2021. REUTERS/Marco Bello

U.S. FDA clears Pfizer COVID-19 booster for older and at-risk Americans

WASHINGTON, Sept 22 (Reuters) – The U.S. Food and Drug Administration on Wednesday authorized a booster dose of the Pfizer Inc and BioNTech COVID-19 vaccine for those 65 and older,…

Read More
A healthcare worker holds a vial of the Moderna COVID-19 Vaccine at a pop-up vaccination site operated by SOMOS Community Care during the coronavirus disease (COVID-19) pandemic in Manhattan in New York City, New York, U.S., January 29, 2021. REUTERS/Mike Segar/File Photo/File Photo

Moderna says its COVID-19 shot 93% effective six months after second dose

(Reuters) – Moderna Inc said on Thursday its COVID–19 shot was about 93% effective through six months after the second dose, showing hardly any change from the 94% efficacy reported in its original clinical trial. That compares favorably to data from Pfizer Inc and BioNTech SE last…

Read More
Photo by JACK GUEZ / AFP

BioNTech produces 10 times more antibodies than Sinovac: Hong Kong study

Hong Kong, China (AFP) – People who received BioNTech’s coronavirus vaccine had ten times the amount of antibodies than those given China’s Sinovac, a Hong Kong study has shown, adding to growing…

Read More
Photo by WANG ZHAO / AFP

Sinovac vaccine has 71-91% efficacy against COVID-19 Alpha variant – MOPH

Thailand’s Public Health Ministry announced the results of a real world study of the efficacy of the Chinese-made Sinovac vaccine conducted in Thailand today (Monday), showing that two doses of…

Read More

Page 1 of 1

Login

Welcome! Login in to your account

Remember me Lost your password?

Lost Password